Latest News about NVS
Recent news which mentions NVS
From MarketWatch
From Benzinga
Novartis' Sandoz Foresees Rapid Growth Post Spin-Off in Generics Market Amid Upcoming Patent Expirations
June 08, 2023
Tickers
NVS
From Benzinga
From MarketWatch
From Benzinga
From Benzinga
Immix Biopharma's Subsidiary Says Investigational CAR T Therapy Shows 100% Response Rate In Amyloidosis
May 22, 2023
From Benzinga
Why Is AVROBIO (AVRO) Stock Up 83% Today?
May 22, 2023
From InvestorPlace
From MarketWatch
From Benzinga
What's Going On With Immix Biopharma Stock Today
May 03, 2023
From Benzinga
From Benzinga
Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine
May 02, 2023
From Benzinga
Rare Blood Disorder Treatment Breakthrough: Novartis' Candidate Improves Hemoglobin To Near-Normal Levels
April 26, 2023
Tickers
NVS
From Benzinga
After Q1 Review, Novartis Narrows R&D Pipeline To Prioritize High-Value Transformative Medicines
April 25, 2023
Tickers
NVS
From Benzinga
3 Top Biotech Stocks Defying the Bear Market
April 25, 2023
From Motley Fool
Tickers
NVS
From MarketWatch
From Benzinga
Novartis Says Relapsing Multiple Sclerosis Patients Remained Free From Disease Progression For Up Five Years With Kesimpta Treatment
April 20, 2023
Tickers
NVS
From Benzinga
Why Shares of Legend Biotech Jumped Wednesday
April 19, 2023
From Motley Fool
New York Rep. Daniel Goldman Bought Over $50K Worth of Novartis Stock: Here's What You Should Know
April 18, 2023
Tickers
NVS
From Benzinga
2 Best Biotech Stocks to Buy for the Long Haul
April 17, 2023
From Motley Fool
7 Sorry Pharma Stocks to Sell in April Before It’s Too Late
April 16, 2023
From InvestorPlace
Relay Therapeutics' Stock Price Premium Vs Peers Is Justified By Its Platform Technology, Analyst Says
April 13, 2023
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.